231 filings
Page 8 of 12
8-K
gs9oaneq0wmlmd
7 Nov 18
Axovant Announces Second Fiscal Quarter 2018 Financial Results and Corporate Updates
12:00am
8-K
g1pagvkuv8dkigj
2 Oct 18
Departure of Directors or Certain Officers
4:16pm
CT ORDER
hojuhyi dsojk9ztg
28 Aug 18
Confidential treatment order
12:00am
8-K
djwe6o8
17 Aug 18
Submission of Matters to a Vote of Security Holders
4:27pm
S-8
6cas8vv14xrip3i
16 Aug 18
Registration of securities for employees
5:23pm
8-K
qmh2uywtfet1v6ggg4v1
7 Aug 18
Axovant Announces First Fiscal Quarter 2018 Financial Results and Corporate Update
12:00am
8-K
mtjq565if2
9 Jul 18
Entry into a Material Definitive Agreement
6:13am
8-K
9uysqbrpltkddx96
22 Jun 18
Entry into a Material Definitive Agreement
5:28pm
424B5
fbhfj34
22 Jun 18
Prospectus supplement for primary offering
5:28pm
DEF 14C
zpkjlu
18 Jun 18
Information statement
7:00am
PRE 14C
gt77mzi64le50wcf7foc
7 Jun 18
Preliminary information
6:03am
8-K
2z5r7 qeb
6 Jun 18
Axovant Licenses Investigational Gene Therapy for Parkinson’s Disease from Oxford BioMedica and Announces Key Leadership Team Addition
6:02am
8-K/A
gvhsg66jromqzk
14 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K/A
33q7a1lii8fhz39y
7 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
0tmb6snx9 s7qgw51
14 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K/A
w1txk3x2uv1
9 Jan 18
Other Events
12:00am